Supporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program
Key facts
- Who runs it
- University of Manitoba
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 30 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 31 May 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- BRIDGE-ADHD
- Record updated
- 9 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Mothers must be 18 years old or older with both current and elevated symptoms of depression (T-score > 5 on the PHQ-9); Mothers must have a child between the ages of 8 and 12 years old; Both mothers and children must currently live in Manitoba; Mothers must self-report that their child has a diagnosis of ADHD. This will be confirmed by having mothers complete the CBCL (T-score > 65) and through intake interviews with clinicians; Both mothers and children must speak fluent English; Mothers must have neither attempted suicide within the past year nor self-harmed resulting in an injury that either did or should have received medical attention within the past 6 months
Who cannot take part
- not meeting the listed criteria above
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The present research study will evaluate the feasibility and preliminary efficacy of the adapted Building Regulation in Dual Generations program for families of children (8-12 years old) with Attention-Deficit/Hyperactivity Disorder, creating the BRIDGE-ADHD program. The BRIDGE-ADHD program combines 10 weekly online psycho-education sessions with knowledge about ADHD and relevant parenting skills training videos to improve maternal wellbeing and parenting practices, thus supporting children's own psychological wellbeing through an intergenerational approach. This study will specifically evaluate whether the BRIDGE-ADHD program is able to reduce mothers' psychological distress (e.g., depression, anxiety, parenting stress) and simultaneously reduce their children's attention and/or behaviour problems.
The 2 groups in the trial
- BRIDGE-ADHDTreatment being tested
The group that will receive the BRIDGE-ADHD program
- Normative ControlNo study treatment, for comparison
This is a normative control group who will not be receiving any intervention.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 9 November 2026